This document discusses diabetes diagnosis, management, and complications. It begins by comparing the economic costs of diabetes to the War on Terror, finding them similar. It then examines screening guidelines and debates using A1c versus glucose. Management focuses on lifestyle, medications like metformin, insulin, and monitoring. Complications include microvascular issues, cardiovascular disease, and foot problems. The document emphasizes evidence-based prevention and management while acknowledging uncertainty and a patient-centered approach.
9. Who to screen?
• USPTF: Assymptomatic Adults with HTN
(B). All Adults (Insufficient).
• ADA: 18-45, Obese with Risk Factor. All
over 45.
10. Should we use the A1c?
Population Screening in 2010:
1/3 Elevated Fasting Glucose
1/3 Elevated A1c (>6.5)
1/3 Both Fasting Glucose & A1c
J Clin
Endocrinol
Metab 2010
Dec. 95:5289
11. Should we use the A1c?
Longitudinal Cohort Study,
Japan
Fasting Glucose: 6x Hazard Ratio
Elevated A1c: 6x Hazard Ratio
Both: 32x Hazard Ratio
Heianza Y et al.
Lancet, 2011
13. Who to listen to?
• Metaguideline
• Guideline
• Review
• Study
• Preceptor’s Unsourced Opinion
• Google
14. Who to listen to?
• Metaguideline
• Guideline Putting evidence into practice requires
• Review
more guesswork and judgement than you
might think as a 3rd year. Less about
facts, more about hunches.
• Study
• Preceptor’s Unsourced Opinion
• Google
18. Lifestyle Management
• Why does a chocolate chip cookie, with its
warm, sumptuous mounds of chocolate, have
such power over us?
— David Kessler
19. Guilt
• We probably react like rats here. Oral
glucose has measurable affects on
dopaminergic responses in the Amygdala
for 7 days. Gastric infusion doesn’t.
• Changing Diet is harder than giving the
advice.
21. 3 month intervention, SMS
Messages
Patients with SMS messages had 1.16%
drop in A1c compared to controls.
Diabetes Res
Clin Pract. 2011
Aug
22. Medications
• Metformin (Even ER, $4/month)
• Glyburide ( $4/month)
• Contrast: Januvia ($200/month), Actos
($300/month)
Since I include the prices, here,
I’m guessing you have a hunch
about my opinion.
Only oral meds on WHOs Model List of Essential Meds: Metformin, Glyburide.
23. Insulin
• “The most dangerous drug I prescribe”
• Key to management: Matching patients
glucose patterns.
• Glargine, NPH, 70/30, Regular: It depends.
24. Glucose Monitoring
• Somewhere between continuously and
never.
• Test Strips are typically $1 each
• Testing in stable diabetics correlates with
depression (Unactionable result?)
• 10 years ago, I was taught 2x Daily. My
practice now trends toward 0x Daily.
27. A1c in a tweet
• Your A1c is like a candy coating on your
blood cells. It gives an average of the sugar
in your blood over the 3 months blood
cells live.
• Or just use the estimated glucose instead?
~A1c x 29
As fundamental as A1c is, how
many patients don’t grasp it?
39. 35,000 patients (mean age, 62) received
either intensive or
standard glucose-lowering treatment.
After a mean follow-up of 5 years,
intensive glucose lowering was not
associated with lower risks for
all-cause mortality and CV death
BMJ 2011 Jul
40. Statins effective in CVD
prevention
20-30% reduction in major coronary
events, strokes, revascularizations with
simvastatin.
Lancet 2003.
46. Let’s not get too
Doctor-centered
• Medication adherence probably matters
more for reducing CVD. Apparently, the
statin only works if the patient swallows it
regularly.
• Cost is still a major factor for patients.
• Wouldn’t we get more bang from getting at
the 1 out of 3 diabetics that isn’t
diagnosed?
47. The future of Diabetes
Low Agency High Agency
Diabetes is our Map for treating
Certain
destiny diabetes
Who knows what Let’s build the
Uncertain
we’ll do someday future of diabetes